Butwick AJ et al. |
Second-line uterotonics and the risk of hemorrhage-related morbidity. |
2015 |
Am. J. Obstet. Gynecol. |
pmid:25582104
|
Butwick AJ et al. |
Risk factors for obstetric morbidity in patients with uterine atony undergoing caesarean delivery. |
2014 |
Br J Anaesth |
pmid:24907281
|
Barney OJ et al. |
A case of pulmonary oedema secondary to carboprost. |
2012 |
J Obstet Gynaecol |
pmid:22779974
|
Chelmow D |
Postpartum haemorrhage: prevention. |
2011 |
BMJ Clin Evid |
pmid:21463537
|
Chen QJ et al. |
Mifepristone in combination with prostaglandins for termination of 10-16 weeks' gestation: a systematic review. |
2011 |
Eur. J. Obstet. Gynecol. Reprod. Biol. |
pmid:21741747
|
Milchev N et al. |
[The use of carboprost tromethamole for prevention and treatment of postpartal haemorrhage]. |
2011 |
Akush Ginekol (Sofiia) |
pmid:21913565
|
Zou LY and Fan L |
[Induced termination of second and third trimester pregnancy in women with scarred uterus]. |
2010 |
Zhonghua Fu Chan Ke Za Zhi |
pmid:20367920
|
Vaid A et al. |
A randomized controlled trial of prophylactic sublingual misoprostol versus intramuscular methyl-ergometrine versus intramuscular 15-methyl PGF2alpha in active management of third stage of labor. |
2009 |
Arch. Gynecol. Obstet. |
pmid:19277690
|
Sundaram S et al. |
Rectal misoprostol vs 15-methyl prostaglandin F2alpha for retained placenta after second-trimester delivery. |
2009 |
Am. J. Obstet. Gynecol. |
pmid:19136084
|
Marinov B |
[Application of Pfizer drugs in the obstetrics and gynecology practice]. |
2009 |
Akush Ginekol (Sofiia) |
pmid:20383932
|